In short
Terbinafine Hydrochloride, commonly known as Lamisil, is an antifungal medication that has been the subject of several clinical trials. These studies aim to evaluate its effectiveness, safety, and new delivery methods for treating various fungal infections, particularly onychomycosis (toenail fungus) and tinea capitis (scalp ringworm). The trials explore different formulations, including oral tablets, topical solutions, and innovative delivery systems, to improve treatment outcomes for patients with these persistent fungal conditions.
At a glance
- Drug Formulations
- Oral tablets (250 mg), topical solutions (1% and 10%), nail lacquers, creams, gels
- Main Conditions Treated
- Onychomycosis (toenail fungus), Tinea Capitis (scalp ringworm)
- Treatment Durations
- Ranging from 7 days to 48 weeks, depending on the study and condition
- Key Outcome Measures
- Complete cure rates, mycological cure, clinical effectiveness, safety assessments
- Innovative Approaches
- Iontophoretic delivery, nail lacquer formulations
- Patient Populations
- Adults with onychomycosis, children with tinea capitis, healthy subjects for bioequivalence studies
- Comparison Studies
- Bioequivalence studies comparing generic versions to brand-name Lamisil
What is Terbinafine Hydrochloride?
Terbinafine Hydrochloride is an antifungal medication used to treat various fungal infections. It's also known by the brand name Lamisil. This drug belongs to a class of medications called allylamine antifungal agents, which work by stopping the growth of fungi.
What Conditions Does Terbinafine Treat?
Terbinafine is used to treat several fungal infections, including:
- Onychomycosis: This is a fungal infection of the toenails or fingernails, also known as nail fungus.
- Tinea pedis: Commonly known as athlete's foot, this is a fungal infection of the feet.
- Tinea capitis: This is a fungal infection of the scalp, primarily occurring in children.
- Oral candidiasis: Also known as thrush, this is a fungal infection in the mouth. Terbinafine has been studied for use in HIV-positive patients with thrush that hasn't responded to other treatments.
Available Formulations
Terbinafine Hydrochloride is available in several forms:
- Oral tablets: Usually 250 mg, taken once daily.
- Topical cream: A 1% formulation applied directly to the skin.
- Nail lacquer: A 10% solution applied directly to affected nails.
- Topical gel: Used in some studies for iontophoretic delivery (a method using a small electric charge to deliver the medication through the skin).
How Does Terbinafine Work?
Terbinafine works by interfering with the fungal cell's ability to produce a substance called ergosterol, which is essential for the fungal cell membrane. Without ergosterol, the fungus cannot maintain its cell structure and eventually dies. This mechanism allows terbinafine to effectively combat a wide range of fungal infections.
Efficacy of Terbinafine
The effectiveness of terbinafine varies depending on the condition being treated and the formulation used:
- For onychomycosis (nail fungus), studies have looked at "complete cure" rates, which means both elimination of the fungus and improvement in the appearance of the nail. In one study, this was assessed after 24 or 48 weeks of treatment.
- For tinea pedis (athlete's foot), one study compared a single application of terbinafine to other treatments, assessing effectiveness after 6 weeks.
- For tinea capitis (scalp fungal infection), a study compared terbinafine to another antifungal medication called griseofulvin, looking at complete cure rates after 10 weeks of treatment.
Safety and Side Effects
Like all medications, terbinafine can cause side effects. The safety profile can vary depending on the formulation and duration of use. Common measures of safety in clinical trials include:
- The number of adverse events (side effects) reported by patients
- The number of serious adverse events
- The number of patients who had to stop treatment due to side effects
Specific side effects aren't detailed in the provided studies, but patients should discuss potential risks with their healthcare provider before starting treatment.
Ongoing Research
Research on terbinafine is ongoing, with studies looking at:
- New formulations, such as nail lacquers and gels, which may improve delivery of the medication to infected nails.
- Comparing the effectiveness of terbinafine to other antifungal medications.
- The use of terbinafine in specific populations, such as HIV-positive patients with resistant fungal infections.
- Different treatment durations to determine the optimal length of therapy.
As with any medication, patients should always consult with their healthcare provider to determine if terbinafine is appropriate for their specific condition and to understand the potential benefits and risks of treatment.